Norlase develops next-generation laser solutions for the treatment of retinal and glaucoma disease.
Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2021 | Series B | £7.15M | 1 |
West Hill Capital
|
— | Detail |
| Jan 10, 2021 | Secondary Market | — | 1 | — | — | Detail |
| Sep 1, 2020 | Series Unknown | $4.10M | 1 | — | — | Detail |
| Apr 10, 2019 | Series A | $4.60M | — | — | — | Detail |
| Nov 1, 2018 | Grant | $2.80M | — | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
West Hill Capital
|
Yes | Series B |
Nordic Secondary Fund
|
— | Secondary Market |
EASME - EU Executive Agency for SMEs
|
— | Grant |